|
|
||||||||
The Journal of Immunology, Vol 158, Issue 12 5765-5772, Copyright © 1997 by American Association of Immunologists
ARTICLES |
MJ Smyth
Cellular Cytotoxicity Laboratory, The Austin Research Institute, Heidelberg, Victoria, Australia. mj_smyth@muwayf.unimelb.edu.au
Using a mouse allospecific lymph node (LN) CTL (H-2b) response to transplanted cells (H-2k), effector cells were shown to lyse C3H/HeJ or L929-Fas (H-2k) target cells in either a perforin-dependent or a Fas ligand (FasL)-dependent manner. C3H/HeJ.lpr targets or L929 targets lacking Fas were not sensitive to these effectors generated in perforin- deficient (Po) mice. By contrast, C3H/HeJ.lpr target cells and L929 were as responsive as C3H/HeJ and L929-Fas targets to the effectors generated in perforin wild-type (P+/+) mice. To measure potential bystander lysis in allogeneic responses, these same effector LN from either C57BL/6 P+/+ or P(o) mice were examined for lysis of C3H/HeJ (or C3H/HeJ.lpr) or L929-Fas (or L929) cocultured with 51Cr-labeled C57BL/6 (H-2b) target cells. Bystander lysis of C57BL/6 targets was observed only in those allogeneic responses where FasL was the defined mechanism of lysis. By contrast, perforin-mediated lysis was restricted by allo- recognition. Syngeneic (H-2b) targets that were not sensitive to Fas- mediated lysis were not lysed in a bystander fashion. Depletion of subsets of LN Po effectors (b anti-k) demonstrated that CD4+ T cells were primarily responsible for FasL-mediated direct and bystander lysis. FasL-mediated bystander lysis was also observed in H-2k anti-b reactions, except when the effectors were FasL mutant (gld). These data suggest that CTL responses to foreign Ag may evoke a certain amount of collateral damage to local host Fas-sensitive cells.
This article has been cited by other articles:
![]() |
M.-T. Rubio, T. I. Saito, K. Kattleman, G. Zhao, J. Buchli, and M. Sykes Mechanisms of the Antitumor Responses and Host-versus-Graft Reactions Induced by Recipient Leukocyte Infusions in Mixed Chimeras Prepared with Nonmyeloablative Conditioning: A Critical Role for Recipient CD4+ T Cells and Recipient Leukocyte Infusion-Derived IFN-{gamma}-Producing CD8+ T Cells J. Immunol., July 15, 2005; 175(2): 665 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ganea and M. Delgado VASOACTIVE INTESTINAL PEPTIDE (VIP) AND PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AS MODULATORS OF BOTH INNATE AND ADAPTIVE IMMUNITY Crit. Rev. Oral. Biol. Med., May 1, 2002; 13(3): 229 - 237. [Abstract] [Full Text] |
||||
![]() |
E. J. Suchin, P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question J. Immunol., January 15, 2001; 166(2): 973 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit T Cell-Mediated Cytotoxicity by Inhibiting Fas Ligand Expression J. Immunol., July 1, 2000; 165(1): 114 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Gagnon, F. A. Ennis, and A. L. Rothman Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones J. Virol., May 1, 1999; 73(5): 3623 - 3629. [Abstract] [Full Text] |
||||
![]() |
N. Kayagaki, N. Yamaguchi, M. Nakayama, A. Kawasaki, H. Akiba, K. Okumura, and H. Yagita Involvement of TNF-Related Apoptosis-Inducing Ligand in Human CD4+ T Cell-Mediated Cytotoxicity J. Immunol., March 1, 1999; 162(5): 2639 - 2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-h. Li, D. Rosen, D. Ronen, C. K. Behrens, P. H. Krammer, W. R. Clark, and G. Berke The Regulation of CD95 Ligand Expression and Function in CTL J. Immunol., October 15, 1998; 161(8): 3943 - 3949. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Sayers, A. D. Brooks, J.-K. Lee, R. G. Fenton, K. L. Komschlies, J. M. Wigginton, R. Winkler-Pickett, and R. H. Wiltrout Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells J. Immunol., October 15, 1998; 161(8): 3957 - 3965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Smyth, E. Krasovskis, and R. W. Johnstone Fas Ligand-Mediated Lysis of Self Bystander Targets by Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes J. Virol., July 1, 1998; 72(7): 5948 - 5954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Smyth and J. A. Trapani The Relative Role of Lymphocyte Granule Exocytosis versus Death Receptor-Mediated Cytotoxicity in Viral Pathophysiology J. Virol., January 1, 1998; 72(1): 1 - 9. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |